Latest period
$359.00M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2024)
$530.00M
Latest annual
$0.00
Stock-Based Compensation history chart for Amgen (AMGN) from 1988 to 2025
Latest: $0.00
Stock-Based Compensation growth chart for Amgen (AMGN) from 1988 to 2025
Latest: -100.0%
Stock-Based Compensation history table for Amgen (AMGN) from 1988 to 2025
| 2025 | $0.00 | -100.0% | −$530.00M | ||
| 2024 | $530.00M | +23.0% | +$99.00M | ||
| 2023 | $431.00M | +7.5% | +$30.00M | ||
| 2022 | $401.00M | +17.6% | +$60.00M | ||
| 2021 | $341.00M | +3.3% | +$11.00M | ||
| 2020 | $330.00M | +7.1% | +$22.00M | ||
| 2019 | $308.00M | -1.0% | −$3.00M | ||
| 2018 | $311.00M | -5.5% | −$18.00M | ||
| 2017 | $329.00M | +5.8% | +$18.00M | ||
| 2016 | $311.00M | -3.4% | −$11.00M | ||
| 2015 | $322.00M | -21.1% | −$86.00M | ||
| 2014 | $408.00M | +1.2% | +$5.00M | ||
| 2013 | $403.00M | +11.3% | +$41.00M | ||
| 2012 | $362.00M | +6.2% | +$21.00M | ||
| 2011 | $341.00M | -3.4% | −$12.00M | ||
| 2010 | $353.00M | +24.3% | +$69.00M | ||
| 2009 | $284.00M | — | +$284.00M | ||
| 2008 | $0.00 | — | $0.00 | ||
| 2007 | $0.00 | — | $0.00 | ||
| 2006 | $0.00 | — | $0.00 | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | $0.00 | ||
| 1989 | $0.00 | — | $0.00 | ||
| 1988 | $0.00 | — | — |
- 2025$0.00-100.0%
- 2024$530.00M+23.0%
- 2023$431.00M+7.5%
- 2022$401.00M+17.6%
- 2021$341.00M+3.3%
- 2020$330.00M+7.1%
- 2019$308.00M-1.0%
- 2018$311.00M-5.5%
- 2017$329.00M+5.8%
- 2016$311.00M-3.4%
- 2015$322.00M-21.1%
- 2014$408.00M+1.2%
- 2013$403.00M+11.3%
- 2012$362.00M+6.2%
- 2011$341.00M-3.4%
- 2010$353.00M+24.3%
- 2009$284.00M—
- 2008$0.00—
- 2007$0.00—
- 2006$0.00—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
- 1989$0.00—
- 1988$0.00—
Stock-Based Compensation values are taken from Amgen's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Amgen (AMGN)
Stock-Based Compensation for Amgen (AMGN): headline value $359.00M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Amgen (AMGN) stock-based compensation is $0.00 – plunged 100.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Amgen stock-based compensation compounded at -100.0% per year, with a net decline across the window.
The highest annual stock-based compensation of $530.00M was reported in 2024. The lowest in the available history was $0.00 in 1988.
Amgen Stock-Based Compensation by Year
Amgen Stock-Based Compensation 2025: $0.00
Amgen stock-based compensation in 2025 was $0.00, plunged 100.0% below 2024.
Amgen Stock-Based Compensation 2024: $530.00M
2024's stock-based compensation for Amgen came in at $530.00M, grew 23.0% from 2023. This figure represents the highest annual value in the available history.
Amgen Stock-Based Compensation 2023: $431.00M
Amgen posted stock-based compensation of $431.00M in 2023, grew 7.5% from 2022.
Amgen Stock-Based Compensation 2022: $401.00M
In 2022, Amgen reported stock-based compensation of $401.00M, grew 17.6% from 2021.
Amgen Stock-Based Compensation 2021: $341.00M
Amgen stock-based compensation in 2021 was $341.00M.
See more financial history for Amgen (AMGN).
Sector peers by Stock-Based Compensation
Healthcare peers of Amgen (AMGN), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $310.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $310.00M
- $0.00
- $0.00
- $0.00
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation